Document Detail

An open study to compare the efficacy and tolerability of two diuretic combinations, frusemide plus amiloride and hydrochlorothiazide plus amiloride, in patients with mild to moderate essential hypertension.
MedLine Citation:
PMID:  3371085     Owner:  NLM     Status:  MEDLINE    
Forty-four patients with mild to moderate essential hypertension were entered in an open study to compare the efficacy and tolerability of the two diuretic combinations, frusemide (40 mg) plus amiloride (5 mg) and hydrochlorothiazide (50 mg) plus amiloride (5 mg), as first-line treatment. After a 2-week run-in period when no antihypertensive medication was given, patients were randomized to receive one or other combination at a dose of 1 tablet daily for 2 weeks. Patients either remained on this regimen for a further 8 weeks or, if their blood pressure was not controlled, dosage was increased to 2 tablets daily. In the latter case, patients were re-assessed after 2 weeks, and those who showed a positive response remained in the study for 8 additional weeks. In the 36 patients assessed (18 in each group), both treatments were found to reduce blood pressure effectively in a high percentage of patients treated. Hydrochlorothiazide/amiloride, however, caused a significant reduction in both plasma potassium and sodium levels whereas frusemide/amiloride did not. More adverse events were reported by patients taking frusemide/amiloride, but the majority of these were trivial.
C I Backhouse; J Platt; R J Crawford; S Allman
Related Documents :
16431875 - Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hyp...
3958825 - Chronic afterload reduction in infants and children with primary myocardial disease.
3524185 - Hypokalemia in thiazide-treated systemic hypertension.
17478155 - Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricul...
21993575 - Quality of life among iranian adults before and after rhinoplasty.
3771595 - Repair of the rotator cuff. end-result study of factors influencing reconstruction.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Current medical research and opinion     Volume:  10     ISSN:  0300-7995     ISO Abbreviation:  Curr Med Res Opin     Publication Date:  1988  
Date Detail:
Created Date:  1988-07-12     Completed Date:  1988-07-12     Revised Date:  2010-07-23    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  690-8     Citation Subset:  IM    
Medical Department, Rorer Health Care Ltd., Eastbourne, England.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amiloride / adverse effects,  therapeutic use*
Drug Combinations / adverse effects,  therapeutic use
Furosemide / adverse effects,  therapeutic use*
Heart Rate / drug effects
Hydrochlorothiazide / adverse effects,  therapeutic use*
Hypertension / blood,  drug therapy*,  physiopathology
Middle Aged
Potassium / blood
Random Allocation
Reg. No./Substance:
0/Drug Combinations; 2609-46-3/Amiloride; 54-31-9/Furosemide; 58-93-5/Hydrochlorothiazide; 68529-45-3/amiloride, hydrochlorothiazide drug combination; 7440-09-7/Potassium; 92522-90-2/frumil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  An open comparative study of two diuretic combinations, frusemide/amiloride ('Frumil') and bumetanid...
Next Document:  Local skin reaction caused by the plastic catheter tubing of the continuous subcutaneous insulin inf...